Global BIO Conference 2025 in Boston

Over 20,000 professionals from the global biotech community gathered at this year’s Global BIO Conference.

On June 17th, Welch had the honour of joining the Consulate General of Canada in Boston and an expert panel of Canadian firms to present to international biotech companies considering expansion opportunities into Canada. The presentations highlighted Canada’s competitive advantages in the life sciences sector, including generous tax incentives, a highly skilled talent pool, and a welcoming immigration policy.

Among the key points presented were:

• World-leading R&D investment: Canada boasts the highest per capita spending on research and development in its academic institutions.
• Access to talent: A strong education system and open immigration policies ensure a steady pipeline of skilled professionals.
• Tax incentives: Programs like the Scientific Research and Experimental Development (SR&ED) tax credit offer significant financial benefits to innovators.
• Global market access: Products developed or manufactured in Canada benefit from numerous free trade agreements, allowing companies to export globally without facing reciprocal tariffs.

The presenting team included Joshua Smith, Partner at Welch LLP, Jordan Pynn and Leah Rodin of Stratford IP, Michael Leaver of Kelly Santini LLP, Tina Kotrych and Heather Sullivan from the Canadian Consulate General, and Edward Short of Charles River Laboratories.

A special thank you goes out to Phil Bunsick and Paul Fortin for their instrumental roles in coordinating the Canadian presence at the event.